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Summary
Background Control of tuberculosis in settings with high HIV prevalence is a pressing public health priority. We 
tested two active case-ﬁ nding strategies to target long periods of infectiousness before diagnosis, which is typical of 
HIV-negative tuberculosis and is a key driver of transmission.
Methods Clusters of neighbourhoods in the high-density residential suburbs of Harare, Zimbabwe, were randomised 
to receive six rounds of active case ﬁ nding at 6-monthly intervals by either mobile van or door-to-door visits. 
Randomisation was done by selection of discs of two colours from an opaque bag, with one disc to represent every 
cluster, and one colour allocated to each intervention group before selection began. In both groups, adult (≥16 years) 
residents volunteering chronic cough (≥2 weeks) had two sputum specimens collected for ﬂ uorescence microscopy. 
Community health workers and cluster residents were not masked to intervention allocation, but investigators and 
laboratory staﬀ  were masked to allocation until ﬁ nal analysis. The primary outcome was the cumulative yield of 
smear-positive tuberculosis per 1000 adult residents, compared between intervention groups; analysis was by intention 
to treat. The secondary outcome was change in prevalence of culture-positive tuberculosis from before intervention to 
before round six of intervention in 12% of randomly selected households from the two intervention groups combined; 
analysis was based on participants who provided sputum in the two prevalence surveys. This trial is registered, 
number ISRCTN84352452.
Findings 46 study clusters were identiﬁ ed and randomly allocated equally between intervention groups, with 
55 741 adults in the mobile van group and 54 691 in the door-to-door group at baseline. HIV prevalence was 21% 
(1916/9060) and in the 6 months before intervention the smear-positive case notiﬁ cation rate was 2·8 per 
1000 adults per year. The trial was completed as planned with no adverse events. The mobile van detected 
255 smear-positive patients from 5466 participants submitting sputum compared with 137 of 4711 participants 
identiﬁ ed through door-to-door visits (adjusted risk ratio 1·48, 95% CI 1·11–1·96, p=0·0087). The overall prevalence 
of culture-positive tuberculosis declined from 6·5 per 1000 adults (95% CI 5·1–8·3) to 3·7 per 1000 adults 
(2·6–5·0; adjusted risk ratio 0·59, 95% CI 0·40–0·89, p=0·0112).
Interpretation Wide implementation of active case ﬁ nding, particularly with a mobile van approach, could have rapid 
eﬀ ects on tuberculosis transmission and disease.
Funding Wellcome Trust.
Introduction
Africa has been in the grip of a severe epidemic of 
tuberculosis since the onset of the HIV epidemic: the 
region includes all but one of 15 countries with the 
highest tuberculosis incidences and accounts for 79% 
of the global burden of 1·4 million cases of HIV-related 
tuberculosis.1 Unlike industrialised countries, most 
tuberculosis disease in endemic areas is due to recently 
transmitted rather than remotely acquired infection2 
and most new infections are acquired from casual 
rather than close household contacts.3 As such, 
interventions targeting tuberculosis transmission in 
the community have high potential to rapidly improve 
control, even in settings with high prevalence of 
HIV infection.4
Tuberculosis is characterised by a long period of 
infectiousness before diagnosis, leading to a high burden 
of infectious tuberculosis in the general community.4 
Despite substantial investment in facility-based diagnosis 
and treatment, community control of undiagnosed 
tuberculosis remains poor in Africa.5–9 However, delays 
in reporting of tuberculosis symptoms and subsequent 
diagnosis can be overcome with community-level access 
to diagnostic services.10
Articles
www.thelancet.com   Vol 376   October 9, 2010 1245
Periodic active case ﬁ nding for tuberculosis was 
widely implemented, mainly using chest radiography, 
during a period of rapid decline in tuberculosis 
incidence in the northern hemisphere and some Asian 
countries,11,12 and remains an integral part of tuberculosis 
control in high-risk groups.11,13–15 Community-wide 
interventions can add substantially to facility-based 
services16 and have the potential to fundamentally alter 
the epidemiology of transmissible diseases.17 For 
tuberculosis, however, despite millions of participants 
in active case ﬁ nding during the last century, the broad 
eﬀ ect on disease control has remained uncertain11 
because of the technical diﬃ  culty in assessment of 
meaningful outcomes.18 Since no diagnostic test is 
available for recent tuberculosis infection, the main 
goal to reduce tuberculosis trans-mission rates cannot 
be measured. The closest proxy outcome is the 
prevalence of infectious tuberculosis in the community, 
assessment of which requires thousands of individuals 
to be screened.18
We report the results of DETECTB, a cluster-
randomised study investigating community-level active 
case ﬁ nding for tuberculosis in Harare, Zimbabwe, 
which is an urban setting with high prevalence of HIV 
infection. Two strategies for active case ﬁ nding were 
compared: door-to-door enquiry for chronic cough,19 and 
neighbourhood visits by a mobile van.20 The cluster-
randomised design was chosen to allow cumulative 
yield of smear-positive tuberculosis to be directly 
compared between groups over six intervention rounds, 
spaced at 6-monthly intervals. The broad eﬀ ect of the 
strategies was assessed through prevalence surveys 
before and after the intervention to investigate whether 
culture-positive tuberculosis had become less prevalent 
in the population.
Methods
Study population
46 study clusters were demarcated in residential 
suburbs of Harare, Zimbabwe, aiming for a total 
population of 100 000–120 000 adults aged 16 years or 
older. Cluster boundaries were based on census 
enumeration areas modiﬁ ed with street maps to provide 
0·5 km or more between cluster boundaries, with 
exclusion of informal settlements, apartment blocks, or 
hostels. Each cluster was estimated to include 
2000–3000 adults on the basis of the last census (2002), 
and only formal serviced residential neighbourhoods 
were eligible for inclusion.
Approval was granted by the ethics committees of 
Biomedical Research and Training Institute (Harare, 
Zimbabwe), Medical Research Council of Zimbabwe 
(Harare, Zimbabwe), and London School of Hygiene 
and Tropical Medicine (London, UK). Written informed 
consent was provided by all participants in the 
prevalence surveys and before HIV testing. The protocol 
request to waive the requirement for signed consent 
forms for the active case-ﬁ nding intervention was 
approved for three reasons: individuals with suspected 
tuberculosis were deﬁ ned and investigated in line with 
national policy, except for the community location; 
informed consent could not be taken from participants 
who submitted specimens through other household 
members; and the potential for harm was minimal. 
Leaﬂ ets provided with all specimen containers 
speci ﬁ ed that this study was for research purposes and 
provided other essential information for participants 
(webappendix p 1). 
Randomisation and masking
Study clusters were randomly allocated to receive six 
rounds of active case ﬁ nding at 6-monthly intervals by 
either mobile van (5 days per cluster per round) or door-
to-door enquiry for chronic cough (one enquiry per 
household), with no standard of care intervention. 
Randomisation was done by selection of red and black 
coloured discs (23 of each colour), which were otherwise 
identical, from an opaque bag held above eye-level. Discs 
were withdrawn at a public meeting by community 
advisory board members representing each cluster. 
Before selection began, black was allocated to represent 
the door-to-door group, and red to represent the mobile 
van group. Community health workers and cluster 
residents were not masked to the intervention. However, 
laboratory work and clinical management was done 
without reference to the intervention group, and interim 
data were not analysed by intervention group until the 
ﬁ nal analysis, allowing investigators and laboratory staﬀ  
to be masked to intervention allocation. A monitoring 
system ensured that the two interventions were delivered 
as intended (webappendix p 2).
Procedures 
Both active case-ﬁ nding strategies used community 
workers to identify chronic cough (≥2 weeks) in the 
community, followed by collection of two sputum 
samples per adult for ﬂ uorescence microscopy but not 
culture. Mobile van and door-to-door teams rotated 
through the clusters, taking 24 weeks to complete the 
23 clusters allocated to the intervention group. The 
intervention period (from ﬁ rst cluster of round one to 
last cluster of round six) was from January, 2006, to 
November, 2008. The mobile van was located in each 
cluster for 5 days per intervention round from 9 am to 
4 pm, including Saturday, and used a loudspeaker to 
publicise leaﬂ eting and services provided by one team 
of three lay ﬁ eld workers. Individuals reporting 
symptoms to staﬀ  waiting by the van provided sputum 
samples, and could report symptoms and obtain 
containers on behalf of other individuals within their 
household. Door-to-door enquiry for chronic cough and 
leaﬂ eting was done by two teams of three lay ﬁ eld 
workers. Households were visited up to three times per 
round between 9 am and 4 pm, including one weekend 
For the DETECTB protocol see 
http://www.lshtm.ac.uk/eph/
ide/research/teg/research/
detectb
See Online for webappendix
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visit, until at least one member was present. Specimen 
containers and instructions were left if symptoms were 
volunteered for any household members. Leaﬂ ets 
explained the study rationale and stressed the beneﬁ ts 
to family and friends of early diagnosis of tuberculosis, 
and the important role of HIV-negative tuberculosis in 
persistence of trans mission. No other attempt at 
community mobilisation was made.
Adults who volunteered symptoms provided two 
sputum specimens: one immediate and one early 
morning specimen obtained before eating. Smears 
were made from centrifuged sputum (Sorvall Legend, 
Kendro Scientiﬁ c, Langenselbold, Germany), stained 
with Auramine-O (Sigma-Aldrich Chemie, Buch, 
Spain), and read by ﬂ uorescence microscopy (Leica DM 
1000, Leitz, Wetzlar, Germany); specimens were not 
cultured. In both intervention groups, specimens were 
transported and processed centrally, with positive 
smears reported to the participant’s home within 4 days, 
conﬁ rmation of the participant’s usual residential 
address, and referral for treatment. Negative results 
were not reported back, but participants could access 
facility-level follow-up at their own discretion.21 
Subsequent facility management included conﬁ rmatory 
chest radiography, repeat sputum microscopy and 
culture, and diagnostic HIV testing and counselling, 
with referral to adjacent municipal services for 
treatment of tuberculosis and HIV management 
(webappendix p 3).21
We also used the municipal electronic tuberculosis 
register to identify patients with tuberculosis who were 
registered to addresses within study clusters. These 
diagnoses were then classiﬁ ed as routine or active case 
ﬁ nding through cross-reference and reconciliation with 
study records.
Every dwelling in the study clusters was visited to 
ascertain the number of households within the dwelling 
(deﬁ ned as sharing meals), and the number of adult 
residents per household. This enumeration survey was 
done in 2005–06 before the ﬁ rst round of intervention 
and in 2008 before the sixth round of intervention to 
provide the sampling frame for two cross-sectional 
prevalence surveys. Survey methods have been previously 
described.22 Allocated household identiﬁ ers were then 
used as the sample frame to produce a random sample of 
12% of households from each of the 46 study clusters by 
use of the sample command in Stata. All consenting 
adult members (≥16 years) of selected households were 
then screened for tuberculosis from culture of two 
sputum specimens, with subsequent case ascertainment 
if positive (webappendix p 4). All specimens were cultured 
by use of Lowenstein-Jensen slopes made within the 
laboratory to detect subclinical in addition to symptomatic 
infectious tuberculosis. Participants reporting cough, 
haemoptysis, fever, night sweats, or weight loss also had 
sputum microscopy and chest radiography. Participants 
were asked to provide venous blood for HIV testing, with 
voluntary counselling and testing for those who wanted 
to know their results. HIV testing was done with 
Determine (Abbott Diagnostics, Johannesburg, South 
Africa) and either Unigold (Trinity Biotech, Dublin, 
Ireland) or SD Bioline (Standard Diagnostics, Suwon, 
South Korea).22 Recruitment and specimen collection for 
the second prevalence survey was completed in December, 
2008, with ﬁ nal clinical follow-up of individuals with 
suspected tuberculosis in April, 2009.
The primary outcome measure was the cumulative 
yield of smear-positive tuberculosis per 1000 adult 
residents diagnosed by six rounds of active case ﬁ nding, 
and was compared at the cluster level between 
intervention groups. The secondary outcome measure 
was the change in the point prevalence of infectious 
(culture-positive) tuberculosis from before intervention 
to before round six of intervention in the two intervention 
groups combined. This outcome was analysed at an 
individual level (not cluster level).
Statistical analysis
The primary outcome sample size23 assumed a 
cumulative yield of smear-positive tuberculosis of 
7·5 per 1000 residents, with 100 000 adults providing 
80% power at a 5% level of signiﬁ cance to detect a 
30% increase in cumulative yield per 1000 adults by the 
more eﬀ ective intervention with the coeﬃ  cient of 
variation k=0·20, and a 35% diﬀ erence with k=0·25. 
For the secondary outcome, we assumed 20% of selected 
individuals would not participate and prevalence of 
culture-positive tuberculosis of about 10 per 
1000 participants before intervention, with a 12% 
random sample of residents providing 80% power to 
Figure 1: Trial proﬁ le
*Analysis based on mean population from the two household enumeration surveys.
49 clusters in 11 suburbs assessed for eligibility
(census enumeration areas, geographical
location, nature of housing)
46 clusters in ten eligible suburbs included
3 clusters in one suburb excluded for
failure to meet eligibility criteria
23 clusters (mean of 2378 adult residents per
cluster) allocated to door-to-door group
      23 received intervention
23 clusters (mean of 2424 adult residents per
cluster) allocated to mobile van group
      23 received intervention
23 clusters analysed by intention to treat 
54 691 adult residents recorded before intervention
and 60 455 after ﬁve rounds of intervention*
4711 participants reported tuberculosis 
symptoms for sputum microscopy 
23 clusters analysed by intention to treat 
55 741 adult residents recorded before intervention
and 63 789 after ﬁve rounds of intervention*
5466 participants reported tuberculosis 
symptoms for sputum microscopy 
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detect a 40–50% reduction in prevalence from before 
intervention, dependent on the extent of household 
clustering and design eﬀ ect.
For the primary endpoint, analysis was by intention 
to treat. The mean cumulative yield of smear-positive 
tuberculosis per 1000 adults in each intervention group 
was compared with the t test, and the unadjusted risk 
ratio (RR) was calculated as the ratio of these means.24 
For multivariate analysis, a linear regression model of 
cumulative yield per 1000 adults included community-
level covariates, but not intervention group. The 
adjusted cumulative yield for each cluster was then 
analysed in place of recorded values, with the number 
of degrees of freedom of the t distribution reduced by 
the number of covariates included. As preplanned, a 
similar approach was used to compare participation in 
each intervention group from numbers of adult 
residents submitting sputum. For the secondary 
endpoint, analysis was based on participants who 
provided sputum in the prevalence surveys before 
intervention and before round six of intervention. The 
unadjusted and adjusted RR measuring the change in 
prevalence of culture-positive tuberculosis was 
estimated by use of generalised estimating equation 
regression models with the log link function, accounting 
for neighbourhood clustering.
The need for adjusted analyses was prespeciﬁ ed as 
limited to covariates meeting deﬁ nitions of imbalance; 
in the event that both intervention groups and cross-
sectional surveys were well balanced, the use of 
unadjusted analyses was justiﬁ ed. However, to increase 
robustness, we present post-hoc analyses adjusted for 
four cluster-level variables for comparison of the primary 
endpoint across intervention groups: household 
crowding (proportion of individuals living in house-
holds with ≥2 people per room), male sex (proportion of 
men in adult population), and HIV infection, which are 
the main risk factors for prevalent tuberculosis,22 and 
rates of diagnosis of smear-positive tuberculosis before 
intervention. All analyses were done with Stata 
(version 11.0).
This trial is registered, number ISRCTN84352452.
Role of the funding source
The funder had no role in any aspect of study design or 
analysis, data collection, data analysis, data interpretation, 
writing of the report, or the decision to submit for 
publication. ELC, TB, and TD had full access to all data. 
ELC had ﬁ nal responsibility for the decision to submit 
for publication.
Results
The 46 study clusters eligible for inclusion in the study 
had a combined population size of 110 432 adults at 
baseline, increasing to 124 244 after ﬁ ve rounds of 
intervention (ﬁ gure 1). Eligible suburbs included eight of 
the ten suburbs with the highest rates of diagnosis of 
smear-positive tuberculosis in Harare. In the 12% of 
households randomly selected for survey of tuberculosis 
and HIV prevalence, 10 092 adults (81% of 12 426) provided 
sputum before intervention and 11 211 (77% of 14 569) 
provided sputum after ﬁ ve rounds of intervention, with 
lower participation in men (65% [3970/6151] before 
intervention, 57% [4061/7185] after intervention) than in 
women (98% [6121/6275] before intervention, 97% 
[7150/7384] after intervention; webappendix p 5).
Characteristics assessed at baseline in the household 
enumeration and tuberculosis and HIV prevalence 
surveys were similar between intervention groups 
(table 1). Overall, HIV prevalence was 21% (1916/9060) 
and the prevalence of culture-positive tuberculosis was 
6·5 per 1000 adults. Previous tuberculosis treatment 
was reported by 3% (334/10 089) of participants. During 
the 6 months before intervention, diagnosis of 
smear-positive tuberculosis was diagnosed in 2·8 per 
1000 adults (table 1). The trial was completed as planned 
with no adverse events.
In analysis of the primary outcome, detection of 
smear-positive tuberculosis and the cumulative yield 
Mobile van group Door-to-door group
Household enumeration survey before intervention
Total number of households 20 700 20 719
Total number of adults* 55 741 54 691
Mean number of adults per cluster 
(range)
2424 (1390–3940) 2378 (1180–3182)
Men 24 222/49 221 (49%) 23 650/47 481 (50%)
HIV and tuberculosis prevalence survey before intervention†
Number of participants 5371 4721
Culture-positive tuberculosis 
(per 1000 adults)
35/5371 (6·5) 31/4721 (6·6) 
Smear-positive tuberculosis 
(per 1000 adults)
19/5371 (3·5) 21/4721 (4·4) 
HIV infection 1048/4842 (22%) 868/4218 (21%) 
Age (years) 31·8 (13·7) 30·5 (12·3)
<25 2129/5371 (40%) 2003/4721 (42%)
25–44 2401/5371 (45%) 2071/4721 (44%)
≥45 841/5371 (16%) 647/4721 (14%)
Previous tuberculosis treatment 195/5368 (4%) 139/4721 (3%)
Current smoker 463/5370 (9%) 404/4720 (9%)
Household crowding (≥2 people per 
room)
2655/5361 (50%) 2189/4713 (46%)
Education (secondary or higher) 4412/5367 (82%) 4030/4719 (85%)
Routine tuberculosis register‡
Smear-positive tuberculosis case 
notiﬁ cation in preceding 6 months 
(per 1000 adults per year)
86/55 741 (3·1) 68/54 691 (2·5)
Data are n/N (%) or mean (SD), unless otherwise stated. Summary data are based on available data combined 
across all clusters within each intervention group, unless otherwise stated. *Information on number of adult 
residents was missing for 1% of households. †12 426 adults were randomly selected to participate in the 
survey but data are based on 10 092 adults who provided sputum for tuberculosis screening. ‡Routinely 
diagnosed tuberculosis cases registered to an address within study clusters for the 6 months before the start 
of intervention.
Table 1: Participant characteristics at baseline by source of study data
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was higher in the mobile van group than in the 
door-to-door group during the six rounds of inter-
vention (table 2), and yield per 1000 adults was higher 
for the mobile van group than the door-to-door group at 
every round (ﬁ gure 2). The diﬀ erence between the 
intervention groups remained signiﬁ cant after 
adjustment for cluster-level variables (table 2). The 
cumulative tuberculosis yield per 1000 adults increased 
with increasing cluster HIV prevalence in the mobile 
van group but not in the door-to-door group (interaction 
p=0·0070). The diﬀ erence between the two groups was 
greatest in clusters with HIV prevalence of 20% or 
higher (adjusted RR 2·05, 95% CI 1·33–3·15), with 
little diﬀ erence below 20% (1·08, 0·74–1·57). This eﬀ ect 
was not simple and direct, however, because in patients 
diagnosed with tuberculosis who consented to 
diagnostic HIV testing, HIV prevalence was similar 
between intervention groups: 72% (156/217) in the 
mobile van group, and 67% (74/111) in the 
door-to-door group.
49% (194/392) of smear-positive patients diagnosed 
through active case ﬁ nding were men. Although 
tuberculosis symptoms included chronic cough in most 
cases (82% [207/253] in the mobile van group [data were 
missing for two individuals], and 84% [115/137] in the 
door-to-door group), most patients had not previously 
sought health care. Patients with chronic cough were 
interviewed about previous consultations with health-care 
providers. Of those who agreed to interview, active case 
ﬁ nding was the ﬁ rst consultation for 146 of 199 (73%) in 
the mobile van group, and 91 of 109 (83%) in the door-to-
door group (p=0·0438).
Rates of reporting of tuberculosis symptoms were 
similar in the two groups, with the exception of round 
one, in which participation in the mobile van group was 
substantially higher than in the door-to-door group (data 
Mobile van 
group
Door-to-door 
group
Unadjusted Adjusted 
Risk ratio (95% CI) p value Risk ratio (95% CI)* p value
Analysis of participation
Number of participants 5466 4711 ·· ·· ·· ··
Cumulative participation rate per 1000 adults† 91·5 81·8 ·· ·· ·· ··
Mean (SD) cumulative participation rate per 1000 adults 
per cluster‡
95·9 (35·6) 84·2 (31·5) 1·14 (0·91–1·42) 0·24 1·03 (0·85–1·24) 0·77
Primary outcome analysis
Smear-positive cases 255 137 ·· ·· ·· ··
Cumulative yield per 1000 adults† 4·27 2·38 ·· ·· ·· ··
Mean (SD) cumulative yield per 1000 adults per cluster‡ 4·22 (1·95) 2·46 (1·33) 1·71 (1·27–2·31) 0·0010 1·48 (1·11–1·96) 0·0087
Analysis of smear-negative participants
Number meeting tuberculosis case deﬁ nition§ 241 214 ·· ·· ·· ··
Cumulative yield per 1000 adults† 4·03 3·72 ·· ·· ·· ··
Mean (SD) cumulative yield per 1000 adults per cluster‡ 4·27 (2·40) 3·80 (2·06) 1·12 (0·81–1·56) 0·48 0·88 (0·71–1·09) 0·22
*Adjusted for cluster-level variation in household crowding, male sex, HIV infection, and rates of diagnosis of smear-positive tuberculosis before intervention; analysis of 
participation was also adjusted for mean age. †Based on mean of adult population from two enumeration surveys (59 770 in mobile van group and 57 581 in door-to-door 
group). ‡One participant contributed two disease episodes (smear-positive tuberculosis in two separate rounds). §Participants who were smear negative on community 
specimens and met the case deﬁ nition for tuberculosis on follow-up in the mobile van and door-to-door groups: 44 and 36, respectively, were smear positive on follow-up; 
59 and 48, respectively, were smear negative and culture conﬁ rmed; and 138 and 130, respectively, met deﬁ nitions for culture-negative tuberculosis including response to 
tuberculosis treatment (described by Dimairo and colleagues21).
Table 2: Participation and cumulative yield of smear-positive tuberculosis cases in the community during six rounds of intervention
Figure 2: Detection of smear-positive tuberculosis through active case ﬁ nding
Solid bars show number of cases per 1000 adults diagnosed in each round of 
intervention. Lines show the cumulative rate of diagnosis per 1000 adults. 
The increase in population during the course of the study is assumed to have 
occurred at a constant rate. 
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not shown). During the six rounds of intervention, 
10 177 participants submitted sputum, with a similar 
cumulative participation rate in both intervention groups, 
but a higher proportion of smear-positive participants 
recorded in the mobile van group (4·7% [255/5466]) than 
in the door-to-door group (2·9% [137/4711]; table 2). At 
cluster level, cumulative rates for submission of sputum 
and diagnostic yield were signiﬁ cantly correlated 
(r=0·55). Notably, 3013 participants (55% of 5466) in the 
mobile van group and 3101 (66% of 4711) in door-to-door 
group were women.
As described in the Methods, smear-negative 
participants could attend follow-up, although few did so: 
27% (1387/5202) from the mobile van group and 29% 
(1336/4568) from the door-to-door group. Across both 
intervention groups, an additional 455 smear-negative 
participants with suspected tuberculosis met the case 
deﬁ nition for tuberculosis (table 2), although 268 (59%) 
were smear and culture negative.
In the period from the start of round one to the end of 
round six in each cluster, a total of 472 smear-positive 
patients were diagnosed through active case ﬁ nding, 
including 80 patients (44 in the mobile van group and 
36 in the door-to-door group) whose ﬁ rst smears were 
negative, but who were smear positive on follow-up 
investigations. Routine health services diagnosed an 
additional 670 cases of smear-positive tuberculosis in 
adult residents of study clusters (367 in the mobile-
van group and 303 in the door-to-door group). 
There fore, active case ﬁ nding contributed 472 (41%) of 
1142 smear-positive diagnoses made during the course 
of intervention.
In analysis of the secondary outcome, the overall 
prevalence of culture-positive tuberculosis declined 
substantially by 44% (95% CI 17–62) from before 
intervention to before round six of intervention, and the 
reduction remained signiﬁ cant even after adjustment 
(table 3). Similar results were recorded for smear-
positive disease, for two alternative case deﬁ nitions of 
tuberculosis that included all positive tuberculosis 
cultures combined irrespective of whether tuberculosis 
was conﬁ rmed on follow-up, and for all tuberculosis 
cases meeting case deﬁ nitions for disease irrespective 
of culture result (table 3).
As anticipated in planned analyses deﬁ ned in our 
protocol, the reduction in prevalence of culture-positive 
Before intervention 
(n=10 092)
Before round six of 
intervention (n=11 211)
Unadjusted Adjusted 
Number 
of cases
Prevalence per 
1000 adults 
(95% CI)
Number 
of cases
Prevalence per 
1000 adults 
(95% CI)
Risk ratio 
(95% CI)*
p value Risk ratio (95% CI)* p value
Prespeciﬁ ed analysis of culture-positive conﬁ rmed tuberculosis (secondary outcome)†
Overall 66 6·5 (5·1–8·3) 41 3·7 (2·6–5·0) 0·56 (0·38–0·83) 0·0036 0·59 (0·40–0·89) 0·0112
HIV status‡ ·· ·· ·· ·· ·· ·· ·· 0·1724§
Positive 34 17·7 (12·3–24·7) 24 13·0 (8·4–19·3) 0·74 (0·44–1·24) ·· 0·75 (0·45–1·26) ··
Negative 29 4·1 (2·7–5·8) 13 1·6 (0·9–2·8) 0·40 (0·21–0·78) ·· 0·42 (0·22–0·81) ··
Post-hoc subgroup analyses
Sex ·· ·· ·· ·· ·· ·· ·· 0·2206§
Women 35 5·7 (4·0–7·9) 18 2·5 (1·5–4·0) 0·44 (0·25–0·78) ·· 0·46 (0·25–0·83) ··
Men 31 7·8 (5·3–11·1) 23 5·7 (3·6–8·5) 0·73 (0·43–1·25) ·· 0·75 (0·43–1·31) ··
Intervention group ·· ·· ·· ·· ·· ·· ·· 0·8244§
Mobile van 35 6·5 (4·5–9·1) 21 3·6 (2·2–5·5) 0·54 (0·32–0·93) ·· 0·62 (0·36–1·07) ··
Door-to-door 31 6·6 (4·5–9·3) 20 3·7 (2·3–5·7) 0·56 (0·32–0·99) ·· 0·56 (0·31–1·02) ··
Prespeciﬁ ed analysis of smear-positive conﬁ rmed tuberculosis¶
Overall 40 4·0 (2·8–5·4) 25 2·3 (1·5–3·3) 0·56 (0·34–0·93) 0·0239 0·60 (0·36–1·00) 0·0504
Post-hoc analysis of all culture-positive tuberculosis (including unconﬁ rmed cases)¶
Overall 88 8·7 (7·0–10·7) 55 4·9 (3·7–6·4) 0·56 (0·40–0·79) 0·0009 0·60 (0·42–0·85) 0·0043
Prespeciﬁ ed analysis of all tuberculosis (including culture-negative cases)¶
Overall 91 9·0 (7·3–11·1) 62 5·5 (4·2–7·1) 0·62 (0·45–0·85) 0·0034 0·66 (0·48–0·92) 0·0150
*Neighbourhood clustering was accounted for in unadjusted analyses; in adjusted analyses, further adjustment was made for household crowding, sex, HIV infection, 
and past tuberculosis treatment at an individual level. †As per protocol, includes one repeatedly smear-positive case in the survey before intervention for which cultures 
failed to grow mycobacteria because of contamination, and six culture-positive cases from households selected in the survey after intervention that were detected 
during round six of the intervention (three from each intervention group). ‡HIV status was not ascertained for three participants with culture-positive tuberculosis and 
1029 participants who did not have tuberculosis (culture negative) at the survey before intervention, and for four participants with culture-positive tuberculosis and 
1356 participants who did not have tuberculosis (culture negative) at the survey after intervention. §p value for interaction. ¶As speciﬁ ed in the trial protocol and 
previously described,22 independent evidence of tuberculosis disease was needed before participants with positive tuberculosis cultures were accepted as conﬁ rmed 
tuberculosis, which is standard practice whenever diagnostic tests are used for screening purposes; case ascertainment used repeat smears, cultures, radiography, and 
response to tuberculosis treatment.
Table 3: Prevalence of tuberculosis disease before intervention and before round six of intervention
Articles
1250 www.thelancet.com   Vol 376   October 9, 2010
tuberculosis associated with intervention was greater in 
participants without HIV infection (58% reduction, 
95% CI 19 to 78) than in those with HIV infection (25%, 
–26 to 55), although not signiﬁ cantly so (table 3). Since 
women had more complete participation in both 
prevalence surveys and both intervention groups than 
did men, post-hoc analysis examined the eﬀ ect by sex. 
Although the estimated reduction was greater in women 
(54%, 17 to 75) than in men (25%, –31 to 57), this 
diﬀ erence was not signiﬁ cant. A further post-hoc 
analysis showed little diﬀ erence in the eﬀ ect of 
intervention group on prevalence, with a reduction of 
38% (–7 to 64) in the mobile van group versus 44% 
(–2 to 69) in the door-to-door group (table 3).
During the intervention period, the population in the 
study area increased by 13%. Overall HIV prevalence fell 
slightly from 21% to 19%, with no other major changes 
(webappendix p 6).
Discussion 
We have shown that untargeted periodic active case 
ﬁ nding for symptomatic smear-positive tuberculosis 
repeated once every 6 months made a substantial 
contribution to diagnosis of smear-positive tuberculosis 
in an urban population with high HIV prevalence, and 
to control of infectious tuberculosis (panel). The mobile 
van delivery strategy signiﬁ cantly outperformed door-to-
door enquiry for chronic cough, especially in 
neighbourhoods with high HIV prevalence. By the start 
of intervention round six, infectious tuberculosis in the 
community had fallen by more than 40% from rates 
before intervention, to rates well below those reported 
elsewhere in the region.5–9 This major improvement in 
tuberculosis control in a population with high HIV 
prevalence suggests that such an intervention could 
provide rapid reductions in tuberculosis transmission in 
the community, and could lead to declining rates of new 
tuberculosis cases in individuals with and without HIV 
infection within a few years.
Active case ﬁ nding has been an integral part of 
tuberculosis control in industrialised countries since the 
1920s.11,12,15 Early programmes used radiological screening 
of otherwise untargeted adults, reporting yields as high 
as 30 cases of previously undiagnosed tuberculosis per 
1000 screened in New York City during the early 1930s.11 
Intensive interventions in native Alaskans in the 1950s, 
in whom prevalence was extremely high, led to rapid and 
major reductions in tuberculosis incidence, mortality, 
and transmission in the population within a few years.25 
Elsewhere, however, the eﬀ ect is diﬃ  cult to discern from 
pre-existing downward trends.11,25 Policy from the 1970s 
recommended targeted screening of close contacts of 
patients with tuberculosis, recent immigrants, prisoners, 
homeless people, and people with HIV infection, but not 
general populations.15 In these high-prevalence groups, 
active case ﬁ nding can reduce tuberculosis incidence 
through prevention of secondary cases.13,26
During the past 15 years, global scale-up of facility-
based tuberculosis diagnostic and treatment services 
has greatly improved treatment success rates, but has 
had disappointingly little eﬀ ect on tuberculosis 
incidence.15 Failure to adequately control undiagnosed 
tuberculosis in poor communities, together with an 
increasing prevalence of factors favouring tuberculosis 
transmission and disease, seem to be the key issues 
and enhanced case ﬁ nding is being reconsidered as a 
possible next step in global control.15 However, little 
evidence is available to guide contemporary choices 
about who should be screened, how screening should 
be done and with what frequency, and how to deliver 
services eﬀ ectively.11,15
We chose to use ﬂ uorescence microscopy to screen 
sputum samples from adults volunteering symptoms, 
rather than the more sensitive alternative of radiological 
screening of all adults, because smear-positive patients 
are by far the most infectious and decentralised 
microscopy is already well supported globally and has 
low unit costs. Between three and eight per 1000 adults 
surveyed in four African countries from 2002 to 2009 
were smear positive, about half of whom reported 
chronic cough, providing a simple target linked to 
infectiousness that has a high positive predictive value 
for smear positivity at community level, and consistency 
with facility-based approaches.5,8,9,11,27 Moreover failure to 
provide diagnosis at subclinical stages is not necessarily 
a long-term barrier to tuberculosis control.10,28
In our study, active case ﬁ nding provided the ﬁ rst 
investigation for 77% of smear-positive participants, 
Panel: Research in context 
Systematic review
Before the study started, we searched PubMed for relevant 
articles with search terms including “tuberculosis AND case 
ﬁ nding” as MeSH headings, “tuberculosis” and “case 
ﬁ nding” as search terms, “tuberculosis AND (community OR 
population OR household)”, “tuberculosis AND case-ﬁ nding 
AND clinical trial”, and “(active OR enhanced OR intensiﬁ ed) 
AND tuberculosis AND (case-ﬁ nding OR case ﬁ nding)”. 
References in relevant articles were also screened. In view of 
the long history of active case ﬁ nding, we did not set any 
criteria for assessing quality to avoid exclusion of 
articles published before standard reporting guidelines 
were developed.
Interpretation
Findings of our study show that the mobile van method 
was substantially more eﬀ ective than was door-to-door 
enquiry for identiﬁ cation of patients with previously 
undiagnosed smear-positive tuberculosis. Repeated 
implementation of periodic active case ﬁ nding can 
substantially reduce undiagnosed infectious tuberculosis in 
the community, which is likely to be associated with 
reduced transmission rates. 
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despite the fact that all participants were symptomatic 
and lived within 2 km of a primary clinic. This ﬁ nding 
adds to accumulating evidence that the slow rate at 
which patients with tuberculosis report to health 
facilities is a major rate-limiting step in global eﬀ orts to 
control tuberculosis.5,15,29–31 Competing priorities for time 
and money, fear of diagnosis with an HIV-related 
disease, and the hope of spontaneous resolution all 
contribute to this delay.31,32
The ﬁ nding that the mobile van attracted signiﬁ cantly 
more smear-positive participants than did door-to-door 
enquiry for chronic cough was counterintuitive, but 
especially striking in clusters with high HIV prevalence 
that were also the poorest and most crowded. This 
ﬁ nding was associated with a higher rate of smear 
positivity in the mobile van group than in the door-to-
door group, not an increased rate of participation. 
Reporting of symptoms is more proactive than is 
response to direct enquiry, and more participants in the 
mobile van group reported previous consultations with 
health-care providers than did those in the door-to-door 
group. The mobile van group was potentially associated 
with stigma because consultation for an HIV-related 
disease was done in front of neighbours, but this 
intervention provided increased opportunity for 
encouragement from others, and time to decide to seek 
the intervention and ﬁ nd a convenient moment to do 
so.32 Follow-up house-to-house enquiry added little to 
case ﬁ nding through a mobile clinic in Thailand,20 but 
the study did not investigate the possibility that mobile 
clinics were more eﬀ ective than was house-to-house 
enquiry. Mobile services are often used to provide 
outreach services, including HIV testing, and report 
high participation.33 Unannounced door-to-door 
enquiries for chronic cough are likely to be less sensitive 
than are more intensive approaches to home-based 
case ﬁ nding (for example, face-to-face interview and 
screening of adult members of randomly selected 
households detected additional tuberculosis cases in 
the door-to-door group, despite this survey immediately 
following the last round of intervention in our study), 
but contributed 40% of all cases of smear-positive 
tuberculosis diagnosed in South Korea during 
the 1970s.15
Assessment of the combined eﬀ ect of our two 
intervention strategies through prevalence surveys 
provides a clearer measure of the eﬀ ect on tuberculosis 
control than could be obtained from our primary 
outcome alone: counting cases diagnosed provides little 
insight into how much smear-positive person-time has 
been averted, and does not capture potentially important 
indirect eﬀ ects from reduced tuberculosis transmission 
and more timely reporting of tuberculosis symptoms to 
routine health-care providers between intervention 
rounds. By contrast with the case ﬁ nding outcome, the 
eﬀ ect of intervention on prevalence was very similar 
between the mobile van and door-to-door groups. 
Subanalyses for prevalence had very low power and the 
95% CIs are widely overlapping. But, if these overlaps 
truly indicate absence of diﬀ erence, then patients in the 
door-to-door group were on average at an earlier stage in 
their health-seeking process than were those diagnosed 
through the mobile van and so were further in time 
from routine diagnosis, in which case the two 
intervention groups will have had equivalent eﬀ ect on 
tuberculosis transmission.
The prevalence data also suggest suboptimal 
intervention eﬀ ect in men and in individuals with HIV 
infection. Although neither interaction was signiﬁ cant, 
men tend to have a higher prevalence of undiagnosed 
tuberculosis than do women,5,22,34 and health-seeking 
behaviour varies substantially by sex.31 In the active 
case-ﬁ nding component of this study, participation, but 
not diagnosis, was higher in women than in men. For 
HIV infection, we anticipated that the 6-monthly 
intervals of intervention might be intrinsically more 
likely to aﬀ ect HIV-negative tuberculosis (low incidence 
but typical delay to diagnosis or death of ≥1 year) than 
HIV-positive tuberculosis (high incidence but a brief 
delay to diagnosis or death).4,10,22
Our intervention clusters were fairly homogeneous, 
with no slums or rural clusters, and we assessed only 
two of many case-ﬁ nding approaches.11 High-density 
urban populations are the obvious target for active case 
ﬁ nding in view of their accessibility and high 
tuberculosis burden,5,9 but eﬀ ective rural strategies have 
also been described.35 Other limitations of our study 
include the separation of clusters by areas receiving no 
intervention to avoid cross-contamination, which will 
have diluted any eﬀ ect on transmission rates. Our 
secondary outcome was an uncontrolled before-and-
after comparison, vulnerable to coincidental time 
trends. However, we believe that such trends are 
unlikely to explain the striking reduction in infectious 
tuberculosis because population characteristics 
remained similar during the intervention period, with 
little change in coverage of antiretroviral therapy36 and 
deterioration rather than strengthening of routine 
health and tuberculosis services during the study 
period. Last, suboptimal participation by men in the 
prevalence surveys could have biased our subanalysis 
by sex, although the substantial reduction in infectious 
tuberculosis in women strongly supports our 
conclusions about the eﬀ ectiveness of active 
case ﬁ nding.
Active case ﬁ nding for tuberculosis in the general 
community was discouraged for several decades because 
of high costs of implementation and insuﬃ  cient 
strength of treatment programmes.11,12,15 With the 
successful global scale-up of eﬀ ective tuberculosis 
treatment, however, our results suggest that active case 
ﬁ nding needs re-evaluation in general populations 
wherever tuberculosis incidence or prevalence is high. 
Eﬀ ectiveness should ideally be assessed as cases averted 
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or reduction in prevalence, and these outcomes, not 
cases found, should be used for cost-eﬀ ectiveness 
analysis together with capture of transmission 
dynamics.37 In countries with severe generalised 
epidemics of HIV infection and tuberculosis, including 
the middle-income countries of South Africa and 
Botswana, the aﬀ ordability of active case ﬁ nding in the 
general population needs to be weighed against the 
extremely high ﬁ nancial and societal costs of allowing 
the dual epidemic to rage on.1,38 The eﬀ ect on HIV-
negative tuberculosis that we report is in the range 
needed for countries to meet the Millennium 
Development Goal relating to tuberculosis prevalence,15 
and was achieved in under 3 years. Interventions should 
aim to eﬀ ectively engage men, and, in settings of high 
HIV prevalence, should ideally be accompanied by 
interventions promoting HIV diagnosis linked to 
intensiﬁ ed tuberculosis prevention with antiretroviral 
therapy and isoniazid preventive therapy.4
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